91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Formulation Development Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Formulation Development Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID: 
PB511241129
Publication Date: 
November 11, 2024
Pages: 
107
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 3,950.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Healthcare [2]
Pharma & Healthcare [3]
Description: 

Formulation development is a major area of product/drug development that determines the patentability, lifecycle, and success of a pharmaceutical product. Most pharmaceutical companies outsource formulation services to minimize the time and investment involved in trials.
The global market for Formulation Development Outsourcing was estimated to be worth US$ 35120 million in 2023 and is forecast to a readjusted size of US$ 59300 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Formulation Development Outsourcing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Formulation Development Outsourcing by region & country, by Type, and by Application.
The Formulation Development Outsourcing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Formulation Development Outsourcing.
Market Segmentation
By Company
Charles River Laboratories
Aizant Drug Research Solutions
Catalent
Labcorp
Syngene
Irisys
Intertek Group
Piramal Pharma Solutions
Qiotient Sciences
Patheon
Emergent BioSolutions
Lonza Group
Dr. Reddy's Laboratories
Segment by Type:
Pre-formulation Services
Formulation Optimization
Segment by Application
Pharmaceutical and Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Formulation Development Outsourcing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Formulation Development Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Formulation Development Outsourcing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Market Overview
1.1 Formulation Development Outsourcing Product Introduction
1.2 Global Formulation Development Outsourcing Market Size Forecast
1.3 Formulation Development Outsourcing Market Trends & Drivers
1.3.1 Formulation Development Outsourcing Industry Trends
1.3.2 Formulation Development Outsourcing Market Drivers & Opportunity
1.3.3 Formulation Development Outsourcing Market Challenges
1.3.4 Formulation Development Outsourcing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Formulation Development Outsourcing Players Revenue Ranking (2023)
2.2 Global Formulation Development Outsourcing Revenue by Company (2019-2024)
2.3 Key Companies Formulation Development Outsourcing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Formulation Development Outsourcing Product Offered
2.5 Key Companies Time to Begin Mass Production of Formulation Development Outsourcing
2.6 Formulation Development Outsourcing Market Competitive Analysis
2.6.1 Formulation Development Outsourcing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Formulation Development Outsourcing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Formulation Development Outsourcing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pre-formulation Services
3.1.2 Formulation Optimization
3.2 Global Formulation Development Outsourcing Sales Value by Type
3.2.1 Global Formulation Development Outsourcing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Formulation Development Outsourcing Sales Value, by Type (2019-2030)
3.2.3 Global Formulation Development Outsourcing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biopharmaceutical Companies
4.1.2 Government and Academic Institutes
4.1.3 Others
4.2 Global Formulation Development Outsourcing Sales Value by Application
4.2.1 Global Formulation Development Outsourcing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Formulation Development Outsourcing Sales Value, by Application (2019-2030)
4.2.3 Global Formulation Development Outsourcing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Formulation Development Outsourcing Sales Value by Region
5.1.1 Global Formulation Development Outsourcing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Formulation Development Outsourcing Sales Value by Region (2019-2024)
5.1.3 Global Formulation Development Outsourcing Sales Value by Region (2025-2030)
5.1.4 Global Formulation Development Outsourcing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Formulation Development Outsourcing Sales Value, 2019-2030
5.2.2 North America Formulation Development Outsourcing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Formulation Development Outsourcing Sales Value, 2019-2030
5.3.2 Europe Formulation Development Outsourcing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Formulation Development Outsourcing Sales Value, 2019-2030
5.4.2 Asia Pacific Formulation Development Outsourcing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Formulation Development Outsourcing Sales Value, 2019-2030
5.5.2 South America Formulation Development Outsourcing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Formulation Development Outsourcing Sales Value, 2019-2030
5.6.2 Middle East & Africa Formulation Development Outsourcing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Formulation Development Outsourcing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Formulation Development Outsourcing Sales Value
6.3 United States
6.3.1 United States Formulation Development Outsourcing Sales Value, 2019-2030
6.3.2 United States Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Formulation Development Outsourcing Sales Value, 2019-2030
6.4.2 Europe Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Formulation Development Outsourcing Sales Value, 2019-2030
6.5.2 China Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Formulation Development Outsourcing Sales Value, 2019-2030
6.6.2 Japan Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Formulation Development Outsourcing Sales Value, 2019-2030
6.7.2 South Korea Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Formulation Development Outsourcing Sales Value, 2019-2030
6.8.2 Southeast Asia Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Formulation Development Outsourcing Sales Value, 2019-2030
6.9.2 India Formulation Development Outsourcing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Formulation Development Outsourcing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Profile
7.1.2 Charles River Laboratories Main Business
7.1.3 Charles River Laboratories Formulation Development Outsourcing Products, Services and Solutions
7.1.4 Charles River Laboratories Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.1.5 Charles River Laboratories Recent Developments
7.2 Aizant Drug Research Solutions
7.2.1 Aizant Drug Research Solutions Profile
7.2.2 Aizant Drug Research Solutions Main Business
7.2.3 Aizant Drug Research Solutions Formulation Development Outsourcing Products, Services and Solutions
7.2.4 Aizant Drug Research Solutions Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.2.5 Aizant Drug Research Solutions Recent Developments
7.3 Catalent
7.3.1 Catalent Profile
7.3.2 Catalent Main Business
7.3.3 Catalent Formulation Development Outsourcing Products, Services and Solutions
7.3.4 Catalent Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.3.5 Labcorp Recent Developments
7.4 Labcorp
7.4.1 Labcorp Profile
7.4.2 Labcorp Main Business
7.4.3 Labcorp Formulation Development Outsourcing Products, Services and Solutions
7.4.4 Labcorp Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.4.5 Labcorp Recent Developments
7.5 Syngene
7.5.1 Syngene Profile
7.5.2 Syngene Main Business
7.5.3 Syngene Formulation Development Outsourcing Products, Services and Solutions
7.5.4 Syngene Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.5.5 Syngene Recent Developments
7.6 Irisys
7.6.1 Irisys Profile
7.6.2 Irisys Main Business
7.6.3 Irisys Formulation Development Outsourcing Products, Services and Solutions
7.6.4 Irisys Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.6.5 Irisys Recent Developments
7.7 Intertek Group
7.7.1 Intertek Group Profile
7.7.2 Intertek Group Main Business
7.7.3 Intertek Group Formulation Development Outsourcing Products, Services and Solutions
7.7.4 Intertek Group Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.7.5 Intertek Group Recent Developments
7.8 Piramal Pharma Solutions
7.8.1 Piramal Pharma Solutions Profile
7.8.2 Piramal Pharma Solutions Main Business
7.8.3 Piramal Pharma Solutions Formulation Development Outsourcing Products, Services and Solutions
7.8.4 Piramal Pharma Solutions Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.8.5 Piramal Pharma Solutions Recent Developments
7.9 Qiotient Sciences
7.9.1 Qiotient Sciences Profile
7.9.2 Qiotient Sciences Main Business
7.9.3 Qiotient Sciences Formulation Development Outsourcing Products, Services and Solutions
7.9.4 Qiotient Sciences Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.9.5 Qiotient Sciences Recent Developments
7.10 Patheon
7.10.1 Patheon Profile
7.10.2 Patheon Main Business
7.10.3 Patheon Formulation Development Outsourcing Products, Services and Solutions
7.10.4 Patheon Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.10.5 Patheon Recent Developments
7.11 Emergent BioSolutions
7.11.1 Emergent BioSolutions Profile
7.11.2 Emergent BioSolutions Main Business
7.11.3 Emergent BioSolutions Formulation Development Outsourcing Products, Services and Solutions
7.11.4 Emergent BioSolutions Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.11.5 Emergent BioSolutions Recent Developments
7.12 Lonza Group
7.12.1 Lonza Group Profile
7.12.2 Lonza Group Main Business
7.12.3 Lonza Group Formulation Development Outsourcing Products, Services and Solutions
7.12.4 Lonza Group Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.12.5 Lonza Group Recent Developments
7.13 Dr. Reddy's Laboratories
7.13.1 Dr. Reddy's Laboratories Profile
7.13.2 Dr. Reddy's Laboratories Main Business
7.13.3 Dr. Reddy's Laboratories Formulation Development Outsourcing Products, Services and Solutions
7.13.4 Dr. Reddy's Laboratories Formulation Development Outsourcing Revenue (US$ Million) & (2019-2024)
7.13.5 Dr. Reddy's Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Formulation Development Outsourcing Industrial Chain
8.2 Formulation Development Outsourcing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Formulation Development Outsourcing Sales Model
8.5.2 Sales Channel
8.5.3 Formulation Development Outsourcing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

Charles River Laboratories
Aizant Drug Research Solutions
Catalent
Labcorp
Syngene
Irisys
Intertek Group
Piramal Pharma Solutions
Qiotient Sciences
Patheon
Emergent BioSolutions
Lonza Group
Dr. Reddy's Laboratories

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/formulation-development-outsourcing-global-market-share-and-ranking-overall-sales-and-demand

Links
[1] /countries/global[2] /healthcare[3] /pharma-healthcare